MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Novocure Ltd

Closed

SectorHealthcare

16.99 -5.19

Overview

Share price change

24h

Current

Min

16.84

Max

17.84

Key metrics

By Trading Economics

Income

-35M

-66M

Sales

6.2M

161M

EPS

-0.61

Profit margin

-40.878

Employees

1,488

EBITDA

19M

-11M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+112.93% upside

Dividends

By Dow Jones

Next Earnings

24 Apr 2025

Market Stats

By TradingEconomics

Market Cap

-226M

2.1B

Previous open

22.18

Previous close

16.99

News Sentiment

By Acuity

50%

50%

180 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Novocure Ltd Chart

Past performance is not a reliable indicator of future results.

Related News

15 Oct 2024, 21:35 UTC

Major Market Movers

Novocure Shares Rise After FDA Approves Optune Lua Cancer Treatment

16 Oct 2024, 11:43 UTC

Earnings

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, J.B. Hunt, DJT, Novocure, and More -- Barrons.com

16 Oct 2024, 10:40 UTC

Earnings

These Stocks Are Moving the Most Today: ASML, Nvidia, United Airlines, J.B. Hunt, DJT, Novocure, Morgan Stanley, and More -- Barrons.com

16 Oct 2024, 09:27 UTC

Hot Stocks

Stocks to Watch Wednesday: ASML, Morgan Stanley, Novocure, TSM -- WSJ

Peer Comparison

Price change

Novocure Ltd Forecast

Price Target

By TipRanks

112.93% upside

12 Months Forecast

Average 38.2 USD  112.93%

High 42 USD

Low 33 USD

Based on 5 Wall Street analysts offering 12 month price targets forNovocure Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

17.32 / 19.5614Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

180 / 386 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.